Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134979) titled 'Low-dose radiotherapy combined with chemotherapy and immunotherapy in extensive-stage small cell lung cance' on Oct. 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Beijing Shijitan Hospital , Capital Medical University
Condition:
Extensive-stage small cell lung cancer
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-11-15
Target Sample Size: Radiotherapy combined with chemotherapy and immunotherapy:18;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=338777
Disclaimer: Curated by HT Syndication...